Loading...
Granuloma-forming interstitial pneumonia induced by nivolumab: a possible immune-related adverse event of the lung
Nivolumab, a monoclonal antibody targeting the PD-1, has recently been used as a standard treatment for lung cancer, melanoma and renal cell carcinoma. We herein report the case of a patient undergoing treatment for non-small cell lung cancer (NSCLC) who developed interstitial pneumonia which featur...
Na minha lista:
| Udgivet i: | Int Cancer Conf J |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Japan
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498337/ https://ncbi.nlm.nih.gov/pubmed/31149487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0291-0 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|